Biotech Patents ― Equivalency and Exclusions Under European and U.S. Patent Law

Declaring that the fundamental objective of the patent system is to promote technical development for the benefit of society as a whole, Westerlund, an attorney specializing in intellectual property and patents, explores how and to what extent the balance between inventors and third parties has been maintained for biotechnological patents. She llustrates the complex picture behind the British and German biotechnology patent systems, and compares them with each other and with the literal infringement and the doctrine of equivalents as applied under US law. Her overriding purpose is to analyze different consequences of certain components and their interpretations. The book is not indexed. Annotation c. Book News, Inc., Portland, OR (booknews.com)